TP53 and angiosarcoma: The molecular signature of UV-induced damage, TP53 mutations in 59.6% of hemangiosarcoma cases, and PIK3CA pathway alterations [54], provide mechanistic support for solar radiation as a primary driver of cutaneous malignancy in our region.